Published in Proc Natl Acad Sci U S A on November 14, 2007
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. JAMA Neurol (2015) 3.58
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology (2008) 2.66
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. Proc Natl Acad Sci U S A (2010) 2.32
Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci (2009) 2.16
The use of PET in Alzheimer disease. Nat Rev Neurol (2010) 2.13
Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A (2009) 2.04
Association of parental dementia with cognitive and brain MRI measures in middle-aged adults. Neurology (2009) 1.94
Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition (2010) 1.89
The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis (2010) 1.60
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci (2010) 1.50
White matter is altered with parental family history of Alzheimer's disease. Alzheimers Dement (2010) 1.45
Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology (2010) 1.41
The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp Neurol (2009) 1.36
The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype. Alzheimers Dement (2011) 1.35
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta (2013) 1.34
White matter in aging and cognition: a cross-sectional study of microstructure in adults aged eighteen to eighty-three. Dev Neuropsychol (2010) 1.33
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis (2010) 1.28
Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology (2011) 1.23
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging (2010) 1.22
Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxid Redox Signal (2011) 1.21
The neurodegenerative mitochondriopathies. J Alzheimers Dis (2009) 1.14
Amyloid burden and neural function in people at risk for Alzheimer's Disease. Neurobiol Aging (2013) 1.14
Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints. Neurobiol Aging (2012) 1.13
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum Genomics (2010) 1.12
Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies. J Clin Neurol (2009) 1.06
Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence. Biochim Biophys Acta (2010) 1.06
Family history of Alzheimer's disease and hippocampal structure in healthy people. Am J Psychiatry (2010) 1.05
Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. J Alzheimers Dis (2011) 1.04
Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. Cereb Cortex (2012) 1.01
Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's. Biol Psychiatry (2010) 0.98
Mitochondria in neurodegeneration. Adv Exp Med Biol (2012) 0.97
Alzheimer disease family history impacts resting state functional connectivity. Ann Neurol (2012) 0.97
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents. Neurobiol Aging (2012) 0.96
Structural brain changes in normal individuals with a maternal history of Alzheimer's. Neurobiol Aging (2011) 0.94
Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol Dis (2012) 0.93
Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging. PLoS One (2012) 0.92
Is Alzheimer's disease a systemic disease? Biochim Biophys Acta (2014) 0.92
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging (2013) 0.91
Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases. Curr Pharm Des (2011) 0.90
Early detection of Alzheimer's disease with PET imaging. Neurodegener Dis (2010) 0.90
Midlife predictors of Alzheimer's disease. Maturitas (2009) 0.89
Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention. Adv Pharmacol (2012) 0.89
Failing compensatory mechanisms during working memory in older apolipoprotein E-epsilon4 healthy adults. Brain Imaging Behav (2010) 0.89
PET/CT in diagnosis of dementia. Ann N Y Acad Sci (2011) 0.89
Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD. Neurology (2014) 0.88
Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. J Prev Alzheimers Dis (2014) 0.88
Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention. PLoS One (2013) 0.88
White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease. Neuroimage Clin (2014) 0.88
Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. PLoS One (2013) 0.86
FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? Q J Nucl Med Mol Imaging (2011) 0.86
Genetic architecture of declarative memory: implications for complex illnesses. Neuroscientist (2011) 0.85
Polymorphic variation in cytochrome oxidase subunit genes. J Alzheimers Dis (2010) 0.85
CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease. Nucleic Acids Res (2013) 0.85
Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage. Biochim Biophys Acta (2013) 0.84
Using biomarkers to improve detection of Alzheimer's disease. Neurodegener Dis Manag (2011) 0.84
Maternal family history is associated with Alzheimer's disease biomarkers. J Alzheimers Dis (2012) 0.84
Family history and APOE-4 genetic risk in Alzheimer's disease. Neuropsychol Rev (2012) 0.83
Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives. PLoS One (2013) 0.82
Maternal transmission of Alzheimer disease. Alzheimer Dis Assoc Disord (2012) 0.81
Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies. Aging Dis (2016) 0.81
PET sheds light on Alzheimer's disease genetic risk. Proc Natl Acad Sci U S A (2007) 0.81
Hippocampal responsiveness to 17β-estradiol and equol after long-term ovariectomy: implication for a therapeutic window of opportunity. Brain Res (2011) 0.81
Rethinking on the concept of biomarkers in preclinical Alzheimer's disease. Neurol Sci (2016) 0.80
Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study. BMJ Open (2014) 0.80
Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals. J Nutr Health Aging (2015) 0.80
Imaging and cerebrospinal fluid biomarkers in the search for Alzheimer's disease mechanisms. Neurodegener Dis (2013) 0.80
Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Front Aging Neurosci (2014) 0.80
Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study. Adv J Mol Imaging (2014) 0.79
Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease. Neurobiol Aging (2011) 0.79
Biomarkers in Alzheimer's disease. Front Neurol (2011) 0.79
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis. Mult Scler Int (2015) 0.78
NSAIDs may protect against age-related brain atrophy. Front Aging Neurosci (2010) 0.78
FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's Disease. Adv J Mol Imaging (2014) 0.78
Machine learning amplifies the effect of parental family history of Alzheimer's disease on list learning strategy. J Int Neuropsychol Soc (2012) 0.78
Cognitively normal individuals with AD parents may be at risk for developing aging-related cortical thinning patterns characteristic of AD. Neuroimage (2012) 0.78
Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring. Neurobiol Aging (2015) 0.77
The concept of FDG-PET endophenotype in Alzheimer's disease. Neurol Sci (2011) 0.77
Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers' Risk of Alzheimer's Disease. Curr Nutr Rep (2015) 0.76
Brain atrophy rates in first degree relatives at risk for Alzheimer's. Neuroimage Clin (2014) 0.76
Multiple Imputation of a Randomly Censored Covariate Improves Logistic Regression Analysis. J Appl Stat (2016) 0.75
A diffusion model analysis of episodic recognition in preclinical individuals with a family history for Alzheimer's disease: The adult children study. Neuropsychology (2016) 0.75
Linear Regression with a Randomly Censored Covariate: Application to an Alzheimer's Study. J R Stat Soc Ser C Appl Stat (2016) 0.75
Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration. Front Immunol (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology (1983) 30.77
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp (1996) 13.15
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem (1977) 11.55
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
Mild cognitive impairment. Lancet (2006) 10.21
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol (1997) 10.06
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A (2003) 6.46
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 4.26
Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet (1974) 3.91
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A (2001) 3.86
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology (2003) 3.60
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging (2003) 3.50
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging (2005) 3.32
Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA (2002) 3.16
A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89
Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology (1997) 2.85
Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. Genet Med (2004) 2.82
The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci (2006) 2.34
Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology (2005) 2.24
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med (2006) 2.17
New frontiers in Alzheimer's disease genetics. Neuron (2001) 2.17
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology (2004) 2.07
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Med (2005) 2.05
Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab (1985) 1.96
Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci (2001) 1.88
Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol (2000) 1.80
A new definition of Alzheimer's disease: a hippocampal dementia. Lancet (1985) 1.73
Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem (1994) 1.69
Variability of familial risk of Alzheimer disease across the late life span. Arch Gen Psychiatry (2005) 1.63
Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology (1996) 1.59
Evidence for parent of origin effect in late-onset Alzheimer disease. Am J Med Genet (2002) 1.20
Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies. AJNR Am J Neuroradiol (1986) 1.18
The construction of viable nuclear-cytoplasmic hybrid cells by nuclear transplantation. Cell (1976) 1.15
Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease. Am J Med Genet (1999) 1.09
Quantitation of the human basal ganglia with positron emission tomography: a phantom study of the effect of contrast and axial positioning. IEEE Trans Med Imaging (1991) 1.02
Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree. Brain (1995) 0.99
Age-associated memory loss: initial neuropsychological and cerebral metabolic findings of a longitudinal study. Int Psychogeriatr (1994) 0.94
Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J Neuropathol Exp Neurol (1994) 0.94
Alzheimer's disease. Lancet (2006) 9.15
Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging (2003) 2.96
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. Proc Natl Acad Sci U S A (2010) 2.32
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging (2008) 2.25
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med (2006) 2.17
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging (2009) 2.15
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging (2008) 2.04
Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology (2003) 2.00
Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A (2003) 1.95
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry (2008) 1.93
Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging (2007) 1.90
Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement (2007) 1.82
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol (2013) 1.75
Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry (2007) 1.68
Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment. Anesthesiology (2012) 1.67
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol Aging (2007) 1.61
Does mild cognitive impairment increase the risk of developing postoperative cognitive dysfunction? Am J Surg (2010) 1.51
Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol (2006) 1.41
Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology (2008) 1.41
MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med (2004) 1.37
The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease. Alzheimers Dement (2008) 1.33
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis (2010) 1.28
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease. J Alzheimers Dis (2009) 1.26
(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease. J Nucl Med (2007) 1.23
Changes in brain functional homogeneity in subjects with Alzheimer's disease. Psychiatry Res (2002) 1.18
Mild cognitive impairment (MCI): a historical perspective. Int Psychogeriatr (2007) 1.15
Subjective memory complaints: presence, severity and future outcome in normal older subjects. Dement Geriatr Cogn Disord (2007) 1.14
Emotional and neutral declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes. Psychiatry Res (2009) 1.10
Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimers Dis (2011) 1.08
Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis (2008) 1.08
The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease. Neurobiol Aging (2007) 1.07
Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies. J Clin Neurol (2009) 1.06
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiol Aging (2007) 1.06
TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J Neuroimmunol (2009) 1.05
Subjective memory complaints in aging are associated with elevated cortisol levels. Neurobiol Aging (2005) 1.04
Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiol Aging (2004) 1.03
Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. Eur J Nucl Med Mol Imaging (2005) 1.03
Greater risk of Alzheimer's disease in older adults with insomnia. J Am Geriatr Soc (2011) 1.01
Assessing function and pathology in familial dysautonomia: assessment of temperature perception, sweating and cutaneous innervation. Brain (2004) 0.98
Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Neuroimage (2011) 0.98
Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's. Biol Psychiatry (2010) 0.98
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders. Neurobiol Aging (2010) 0.98
Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J Cereb Blood Flow Metab (2010) 0.97